<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>Nicole Leonie Bertschi</submitter><instrument_platform>Illumina NovaSeq 6000</instrument_platform><study_type>RNA-seq of coding RNA</study_type><organism>Homo sapiens</organism><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-17266</full_dataset_link><description>Effect of Tapinaorf on normal human keratinocytes (NHEK). NHEKs were e treated with tapinarof (1uM) or DMSO (control) for 72 hours.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Sample Collection - Normal human epidermal keratinocyte (NHEK) (Cat. C-12003, Promocell) vials from different donors were obtained and cultured in Dermacult medium (Cat. 100-0500, Stemcell Technologies) containing Keratinocyte Expansion Supplement (Cat. 100-0500, Stemcell Technologies), Hydrocortisone (Cat. 07925, Stemcell Technologies), penicillin (50 U/ml) and streptomycin (50 μg/ml) (Cat. 4-01F00-H, BioConcept). Keratinocytes were cultured in T75 flasks and medium was exchanged every other day. After reaching 90% confluency, keratinocytes were washed with D-PBS (Cat. 37354, Stemcell Technologies) and treated with ACCUTASE (Cat. 07922, Stemcell Technologies). After 5-7 minutes at 37°C, keratinocyte were dislodged with gentle tapping of the plate, transferred to a 15ml conical tube and washed with the keratinocyte medium. For the treatment, keratinocytes were plated into a 12 well plate at a density of 1x 105 cells per well and cultured for 24h in keratinocyte medium. After 24h, the medium was exchanged to keratinocyte medium containing 1.2mM CaCl2 (Cat. C34006, Sigma-Aldrich) and NHEKs were treated with DMSO or tapinarof (1 μM. at. #S9700, Selleck Chemicals). NHEKs were harvested after 3 days of treatment</sample_protocol><sample_protocol>Library Construction - Illumina TruSeq Stranded mRNA protocol (Directional, first strand)</sample_protocol><sample_protocol>Sequencing - The mRNA was sequenced by the Next Generation Sequencing Platform of Bern using paired-end 100 bp sequencing.</sample_protocol><sample_protocol>Nucleic Acid Extraction - The RNeasy Micro Kit (Cat. 74004, Qiagen) was used for total RNA isolation according to manufacturer’s instructions</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><pubmed_authors>Nicole Leonie Bertschi</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq of normal human keratinocytes (NHEK) treated with tapinarof against untreated control</name><description>Effect of Tapinaorf on normal human keratinocytes (NHEK). NHEKs were e treated with tapinarof (1uM) or DMSO (control) for 72 hours.</description><dates><release>2026-07-10T00:00:00Z</release><modification>2026-07-10T01:00:54.707Z</modification><creation>2026-07-01T16:03:46.756Z</creation></dates><accession>E-MTAB-17266</accession><cross_references><ENA>ERP195978</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003738</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>